Genetic variability in morphine sensitivity and tolerance between different strains of rats

Brain Research

Volumn 866, Issue 1-2, 2000, Pages 109-115

  Mas, Magdalena ^a,b   Sabater, Eva ^a   Jesus Olaso M ^a   Horga, José F ^a   Faura, Clara C ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

Genetic variability; Morphine; Pharmacokinetics; Rats; Sensitivity; Tolerance

Indexed keywords

MORPHINE; NALOXONE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SENSITIVITY; DRUG TOLERANCE; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MORPHINE; MORPHINE DERIVATIVES; NOCICEPTORS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TIME FACTORS;

EID: 0034595721     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02255-1     Document Type: Article

References (27)

1. H.K. Beecher, Measurement of Subjective Responses, Oxford University Press, New York, 1959.
2. D. Bowsher, Paradoxical pain, Br. Med. J. 306 (1993) 473-474.
3. D.A. Erase, Is intracellular sodium involved in the mechanism of tolerance to opioid drugs?, Med. Hypotheses 32 (1990) 161-167.
4. B.M. Cox, Drug Tolerance and Physical Dependence, in: W.B. Pratt, P. Taylor (Eds.), Principles of Drug Action. The Basis of Pharmacology, Churchill Livingstone, New York, 1990, pp. 639-690.
5. F.E. D'Amour, D.L. Smith, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72 (1941) 74-79.
6. C.C. Faura, S.L. Collins, R.A. Moore, H.J. McQuay, Systematic review of factors affecting the ratios of morphine and its major metabolites, Pain 74 (1998) 43-53.
7. C.C. Faura, M.J. Olaso, C. Garcia Cabanes, J.F. Horga, Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?, Pain 65 (1996) 25-30.
8. A. Goldstein, P. Sheehan, Tolerance to opioid narcotics. I. Tolerance to the 'running fit' caused by levorphanol in the mouse, J. Pharmacol. Exp. Ther. 169 (1969) 175-184.
9. X. Guitart, J.H. Kogan, M. Berhow, R.Z. Terwilliger, G.K. Aghajanian, E.J. Nestler, Lewis and Fischer rats strains display differences in biochemical, electrophysiological and behavioural parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals, Brain Res. 611 (1993) 7-17.
10. K. Hewett, A.H. Dickenson, H.J. McQuay, Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study, Pain 53 (1993) 59-63.
11. O. Hoffmann, A. Plesan, Z. Wiesenfeld-Hallin, Genetic differences in morphine sensitivity, tolerance and withdrawal in rats, Brain Res. 806 (1998) 232-237.
12. C.K. Kuo, N. Hanioka, Y. Hoshikawa, K. Oguri, H. Yoshimura, Species difference of site-selective glucuronidation of morphine, J. Pharmacobio-Dyn. 14 (1991) 187-193.
13. L. Lasagna, H.K. Beecher, The optimal dose of morphine, J. Am. Med. Assoc. 156 (1954) 230-234.
14. K. Lufty, B. Sadowski, I.S. Kwon, E. Weber, Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia, Eur. J. Pharmacol. 265 (1994) 171-174.
15. J. Mao, D.D. Price, D.J. Mayer, Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C, J. Neurosci. 14 (1994) 2301-2312.
16. L. Menendez, F. Andres-Trelles, A. Hidalgo, A. Baamonde, Involvement of spinal k opioid receptors in a type of footshock induced analgesia in mice, Brain Res. 611 (1993) 264-271.
17. R.W. Milne, R.L. Nation, G.D. Reynolds, A.A. Somogy, J.T. Van Crugten, High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies, J. Chromatogr. 565 (1991) 457-464.
18. J.S. Mogil, B. Kest, B. Sadowski, J.K. Belknap, Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay, J. Pharmacol. Exp. Ther. 276 (1996) 532-544.
19. D.W. Nebert, W.W. Weber, Pharmacogenetics, in: W.B. Pratt, P. Taylor (Eds.), Principles of Drug Action. The Basis of Pharmacology, Churchill Livingstone, New York, 1990, pp. 469-531.
20. C.A. Paronis, S.G. Holtzman, Increased analgesic potency of mu agonists after continuous naloxone infusion in rats, J. Pharmacol. Exp. Ther. 259 (1991) 582-589.
21. K. Shimomura, O. Kamata, S. Ueki, K. Oguri, H. Yoshimura, H. Tsukamoto, Analgesic effect of morphine glucuronides, Tohoku J. Exp. Med. 105 (1971) 45-52.
22. C.B. Smith, H.C. Moises, R.N. Spengler, P.J. Hollingwirth, Changes in α-adrenoreceptors number and function in brain of morphinedependents rats, J. Pharmacol. 161 (1989) 111-119.
23. M.T. Smith, J.A. Watt, T. Cramond, Morphine-3-glucuronide - a potent antagonist of morphine analgesia, Life Sci. 47 (1990) 579-585.
24. N. Suzuki, E. Kalso, PH. Rosenberg, Inthathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats, Eur. J. Pharmacol. 249 (1993) 247-250.
25. R.A. Upton, Simple and reliable method for serial sampling of blood from rats, J. Pharm. Sci. 64 (1975) 112-114.
26. A.L. Vaccarino, L.C. Couret, Relationship between hypothalamicpituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: a strain comparison, Pain 63 (1995) 385-389.
27. M. Zimmermann, Ethical guidelines for investigations of experimental pain in conscious animals, Pain 16 (1983) 109-110.